1256349-48-0
Chemical Structure
Chiauranib
Synonym(s): Ibcasertib; CS2164
- CAS. Nr.: 1256349-48-0
- Formula:C27H21N3O3
- Molecular Weight:435.47
IUPAC Name: N-(2-aminophenyl)-6-((7-methoxyquinolin-4-yl)oxy)-1-naphthamide
InChIKey: BRKWREZNORONDU-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=CC=C1N)C2=C3C=CC(OC4=CC=NC5=CC(OC)=CC=C54)=CC3=CC=C2
Biological Activity: Chiauranib (CS2164) is an orally active multi-target inhibitor against tumor angiogenesis. Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B, and chronic inflammation-related kinase CSF-1R, with IC50 values ranging from 1-9 nM. Chiauranib has strongly anticancer effects[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Chiauranib | 98.97% | Chiauranib (CS2164) is an orally active multi-target inhibitor against tumor angiogenesis. Chiauranib potently inhibits the angiogenesis-related kinases (VEGFR1, VEGFR2, VEGFR3, PDGFRα and c-Kit), mitosis-related kinase Aurora B, and chronic inflammation-related kinase CSF-1R, with IC50 values ranging from 1-9 nM. Chiauranib has strongly anticancer effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.64
HY-182354VEGFR2-IN-84 -
Similarity Score 0.63
HY-15391RLucitanib (Standard) -
Similarity Score 0.62
HY-15391ALucitanib dihydrochloride -
Similarity Score 0.58
HY-117991DW10075 -
Similarity Score 0.58
HY-175513ZWZH-21 -
Similarity Score 0.57
HY-100394NVP-BAW2881 -
Similarity Score 0.57
HY-112417Ki11502 -
Similarity Score 0.57
HY-183150HDAC1-IN-13 -
Similarity Score 0.55
HY-183933K812 -
Explore the MedChemAI to find more analogs
